Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3028% below fair value
$17.59−0.24 (-1.35%)
Close on Nov 19, 2026Market cap $3.03BP/E 8.0Yield –
Acadia Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Acadia Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was $145.63M, down 22.2% year over year. For fiscal 2025 it was $105.15M, down 33.1% from the year before. The highest annual figure on record is $157.20M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.15M | -33.1% |
| FY2024 | Dec 31, 2024 | $157.20M | +844.0% |
| FY2023 | Dec 31, 2023 | $16.65M | – |
| FY2022 | Dec 31, 2022 | -$114.04M | – |
| FY2021 | Dec 31, 2021 | -$126.78M | – |
| FY2020 | Dec 31, 2020 | -$143.75M | – |
| FY2019 | Dec 31, 2019 | -$152.26M | – |
| FY2018 | Dec 31, 2018 | -$169.57M | – |
| FY2017 | Dec 31, 2017 | -$218.57M | – |
| FY2016 | Dec 31, 2016 | -$209.91M | – |
| FY2015 | Dec 31, 2015 | -$123.94M | – |
| FY2014 | Dec 31, 2014 | -$66.61M | – |
| FY2013 | Dec 31, 2013 | -$32.39M | – |
| FY2011 | Dec 31, 2011 | -$19.90M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $95.69M | +50.3% |
| Q1 FY2026 | Mar 31, 2026 | $28.77M | +41.6% |
| Q4 FY2025 | Dec 31, 2025 | -$52.74M | -232.1% |
| Q3 FY2025 | Sep 30, 2025 | $73.90M | +17.0% |
| Q2 FY2025 | Jun 30, 2025 | $63.66M | -25.4% |
| Q1 FY2025 | Mar 31, 2025 | $20.32M | – |
| Q4 FY2024 | Dec 31, 2024 | $39.93M | – |
| Q3 FY2024 | Sep 30, 2024 | $63.18M | – |
| Q4 FY2023 | Dec 31, 2023 | $85.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$727.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$76.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$23.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$25.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$61.23M | – |
| Q4 FY2020 | Dec 31, 2020 | -$29.49M | – |
| Q3 FY2020 | Sep 30, 2020 | -$24.51M | – |
| Q2 FY2020 | Jun 30, 2020 | -$39.82M | – |
| Q1 FY2020 | Mar 31, 2020 | -$49.94M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.91M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.93M | – |
| Q2 FY2019 | Jun 30, 2019 | -$38.42M | – |
| Q1 FY2019 | Mar 31, 2019 | -$65.00M | – |
| Q4 FY2018 | Dec 31, 2018 | -$39.61M | – |
| Q3 FY2018 | Sep 30, 2018 | -$43.30M | – |
| Q2 FY2018 | Jun 30, 2018 | -$40.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$45.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$29.90M | – |
| Q3 FY2017 | Sep 30, 2017 | -$58.46M | – |
| Q2 FY2017 | Jun 30, 2017 | -$59.16M | – |
| Q1 FY2017 | Mar 31, 2017 | -$71.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$61.44M | – |
| Q3 FY2016 | Sep 30, 2016 | -$49.73M | – |
See a number that looks wrong?